Format

Send to

Choose Destination
J Natl Compr Canc Netw. 2014 Apr;12(4):473-83.

Soft tissue sarcoma, version 2.2014.

Author information

1
From 1Fox Chase Cancer Center; 2Huntsman Cancer Institute at the University of Utah; 3The University of Texas MD Anderson Cancer Center; 4UC San Diego Moores Cancer Center; 5Moffitt Cancer Center; 6Memorial Sloan-Kettering Cancer Center; 7Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 8Massachusetts General Hospital Cancer Center; 9Stanford Cancer Institute; 10Dana-Farber/Brigham and Women's Cancer Center; 11University of Alabama at Birmingham Comprehensive Cancer Center; 12Roswell Park Cancer Institute; 13The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 14Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 15The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 16UCSF Helen Diller Family Comprehensive Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18City of Hope Comprehensive Cancer Center; 19Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 20Duke Cancer Institute; 21University of Michigan Comprehensive Cancer Center; 22Vanderbilt-Ingram Cancer Center; 23Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and 24National Comprehensive Cancer Network.

Abstract

These NCCN Guidelines Insights highlight the important updates to the NCCN Guidelines for Soft Tissue Sarcoma (STS) specific to the role of radiation therapy in the management of patients with retroperitoneal/intra-abdominal STS. The guidelines have also included recommendations for genetic testing and counseling for patients with a clinical and/or family history of genetic cancer syndromes associated with a predisposition for the development of STS.

PMID:
24717567
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center